WILLIAM J CHASE Insider Trading $ABBV AbbVie Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WILLIAM J CHASE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WILLIAM J CHASE. WILLIAM J CHASE is EVP, Chief Financial Officer in AbbVie Inc. ($ABBV) and EVP, Finance & Administration in AbbVie Inc. ($ABBV).
WILLIAM J CHASE in AbbVie Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WILLIAM J CHASE: EVP, Finance & Administration, EVP, Chief Financial Officer
Holdings: 169,552 shares
Current Value: $10,283,329
Latest Transaction: Jun 28 2019
$ABBV Market Capitalization: $98.42B
$ABBV Previous Close: $60.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of WILLIAM J CHASE in AbbVie Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2019 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Buy | P | 67.30 | 30,400 | 2,045,920 | 169,552 | 139.2 K to 169.6 K (+21.85 %) |
| Jun 28 2019 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Buy | P | 67.30 | 30,400 | 2,045,920 | 169,552 | 139.2 K to 169.6 K (+21.85 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Option Exercise | A | 79.02 | 60,747 | 4,800,228 | 60,747 | |
| Feb 22 2019 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Grant | A | 0.00 | 8,481 | 0 | 166,428 | 157.9 K to 166.4 K (+5.37 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Grant | A | 0.00 | 14,989 | 0 | 157,947 | 143 K to 157.9 K (+10.48 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Grant | A | 0.00 | 15,945 | 0 | 142,958 | 127 K to 143 K (+12.55 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Grant | A | 0.00 | 22,150 | 0 | 127,013 | 104.9 K to 127 K (+21.12 %) |
| Dec 14 2018 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Finance & Admi ... | Sell | S | 90.00 | 60,000 | 5,400,000 | 104,863 | 164.9 K to 104.9 K (-36.39 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | A | 114.36 | 45,840 | 5,242,262 | 45,840 | |
| Feb 16 2018 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 14,991 | 0 | 231,798 | 216.8 K to 231.8 K (+6.91 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 17,319 | 0 | 216,807 | 199.5 K to 216.8 K (+8.68 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 15,945 | 0 | 199,488 | 183.5 K to 199.5 K (+8.69 %) |
| May 19 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 28.13 | 12,800 | 360,064 | 0 | |
| May 19 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 28.86 | 25,500 | 735,930 | 0 | |
| May 19 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Sell | S | 65.35 | 38,300 | 2,502,905 | 183,543 | 221.8 K to 183.5 K (-17.26 %) |
| May 19 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 28.13 | 12,800 | 360,064 | 221,843 | 209 K to 221.8 K (+6.12 %) |
| May 19 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 28.86 | 25,500 | 735,930 | 209,043 | 183.5 K to 209 K (+13.89 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | A | 61.36 | 100,100 | 6,142,136 | 100,100 | |
| Feb 21 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 15,945 | 0 | 223,755 | 207.8 K to 223.8 K (+7.67 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 35,440 | 0 | 207,810 | 172.4 K to 207.8 K (+20.56 %) |
| Dec 02 2016 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 27.29 | 6,600 | 180,114 | 0 | |
| Dec 02 2016 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Sell | S | 59.19 | 6,600 | 390,654 | 172,370 | 179 K to 172.4 K (-3.69 %) |
| Dec 02 2016 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 27.29 | 6,600 | 180,114 | 178,970 | 172.4 K to 179 K (+3.83 %) |
| Mar 02 2016 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Payment of Exercise | F | 56.00 | 45,658 | 2,556,848 | 172,370 | 218 K to 172.4 K (-20.94 %) |
| Feb 22 2016 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | A | 54.86 | 95,400 | 5,233,644 | 95,400 | |
| Mar 03 2015 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Payment of Exercise | F | 60.50 | 8,192 | 495,616 | 218,028 | 226.2 K to 218 K (-3.62 %) |
| Mar 03 2015 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Payment of Exercise | F | 60.52 | 10,299 | 623,295 | 226,220 | 236.5 K to 226.2 K (-4.35 %) |
| Feb 23 2015 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | A | 58.88 | 110,770 | 6,522,138 | 110,770 | |
| Feb 23 2015 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 56,040 | 0 | 236,519 | 180.5 K to 236.5 K (+31.05 %) |
| Dec 22 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 24.07 | 8,495 | 204,501 | 0 | |
| Dec 22 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Sell | S | 68.00 | 8,495 | 577,660 | 180,068 | 188.6 K to 180.1 K (-4.51 %) |
| Dec 22 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 24.07 | 8,495 | 204,501 | 188,563 | 180.1 K to 188.6 K (+4.72 %) |
| Mar 04 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Sell | S | 51.20 | 100 | 5,120 | 180,068 | 180.2 K to 180.1 K (-0.06 %) |
| Mar 04 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Sell | S | 50.19 | 1,400 | 70,272 | 180,168 | 181.6 K to 180.2 K (-0.77 %) |
| Mar 04 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Sell | S | 50.19 | 2,448 | 122,868 | 181,568 | 184 K to 181.6 K (-1.33 %) |
| Mar 04 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Payment of Exercise | F | 51.91 | 9,873 | 512,507 | 184,016 | 193.9 K to 184 K (-5.09 %) |
| Feb 24 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | A | 51.42 | 92,740 | 4,768,691 | 92,740 | |
| Feb 24 2014 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 53,770 | 0 | 193,889 | 140.1 K to 193.9 K (+38.37 %) |
| Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 35.99 | 3,438 | 123,716 | 0 | |
| Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 35.24 | 1,591 | 56,070 | 0 | |
| Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 34.49 | 1,620 | 55,872 | 0 | |
| Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 28.97 | 963 | 27,895 | 0 | |
| Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Payment of Exercise | F | 54.32 | 6,149 | 334,014 | 140,119 | 146.3 K to 140.1 K (-4.20 %) |
| Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 35.99 | 3,438 | 123,716 | 146,268 | 142.8 K to 146.3 K (+2.41 %) |
| Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 35.24 | 1,591 | 56,070 | 142,830 | 141.2 K to 142.8 K (+1.13 %) |
| Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 34.49 | 1,620 | 55,872 | 141,239 | 139.6 K to 141.2 K (+1.16 %) |
| Dec 20 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 28.97 | 963 | 27,895 | 139,619 | 138.7 K to 139.6 K (+0.69 %) |
| Mar 04 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Payment of Exercise | F | 36.73 | 5,260 | 193,200 | 138,656 | 143.9 K to 138.7 K (-3.65 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | A | 35.88 | 115,830 | 4,155,980 | 115,830 | |
| Feb 19 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Payment of Exercise | F | 37.58 | 2,912 | 109,433 | 143,916 | 146.8 K to 143.9 K (-1.98 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 56,700 | 0 | 146,828 | 90.1 K to 146.8 K (+62.91 %) |
| Feb 08 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 32.43 | 2,177 | 70,592 | 0 | |
| Feb 08 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 32.00 | 2,390 | 76,481 | 0 | |
| Feb 08 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Payment of Exercise | F | 37.14 | 4,188 | 155,542 | 90,128 | 94.3 K to 90.1 K (-4.44 %) |
| Feb 08 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 32.43 | 2,177 | 70,592 | 94,316 | 92.1 K to 94.3 K (+2.36 %) |
| Feb 08 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 32.00 | 2,390 | 76,481 | 92,139 | 89.7 K to 92.1 K (+2.66 %) |
Page: 1